indinavir-sulfate and Anemia--Hemolytic

indinavir-sulfate has been researched along with Anemia--Hemolytic* in 5 studies

Other Studies

5 other study(ies) available for indinavir-sulfate and Anemia--Hemolytic

Article	Year
Haemolytic anaemia associated with indinavir. Postgraduate medical journal, 1999, Volume: 75, Issue:883 Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia, Hemolytic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Male	1999
[Hemolytic anemia associated with indinavir administration]. Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17, Issue:9 Topics: Adult; Anemia, Hemolytic; HIV Protease Inhibitors; Humans; Indinavir; Male	1999
Fatal acute haemolysis in an AIDS patient treated with indinavir. AIDS (London, England), 1998, Mar-26, Volume: 12, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia, Hemolytic; Drug Therapy, Combination; Fatal Outcome; HIV Protease Inhibitors; Humans; Indinavir; Male	1998
[Hemolytic jaundice related to ingestion of indinavir]. Presse medicale (Paris, France : 1983), 1997, Nov-01, Volume: 26, Issue:33 Topics: Anemia, Hemolytic; Anti-HIV Agents; Female; Humans; Indinavir; Middle Aged	1997
Medical alert: hemolytic anemia in Crixivan cohort. Critical Path AIDS project, 1997,Summer, Issue:No 32 Merck is adding a warning label to indinavir (Crixivan) as a result of 20 cases of hemolytic anemia reported among the 140,000 people currently using the drug. The disease causes a premature destruction of red blood cells, and the most common symptoms are fatigue, jaundice and discolored urine. The condition progresses rapidly and requires quick treatment. Mild cases are treated by stopping the drug, moderate cases are treated with the corticosteroid prednisone, and severe cases may require blood transfusions. Topics: Anemia, Hemolytic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir	1997